ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
ESC Premium Access
Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)
Event:
ESC CONGRESS 2017
Topic:
Thrombosis and platelets
Session type:
Satellite Symposium - Experts on the Spot
Sponsored by AstraZeneca
Date:
28 August 2017
Time:
10:15 - 10:45
Session
0
4
presentations
in this session
Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.
Speaker:
Professor R. Mehran (New York, US)
Access
0
Early initiation of dual anti-platelet therapy following an acute coronary syndrome: a clinical case study.
Speaker:
Professor S. James (Uppsala, SE)
Access
0
Open questions - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.
Speaker:
Professor R. Mehran (New York, US)
Speaker:
Professor S. James (Uppsala, SE)
Access
0
Session close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.
Speaker:
Professor R. Mehran (New York, US)
Access
0
5
speakers
from this session
Professor Roxana Mehran
Icahn School of Medicine at Mount Sinai, New York (United States of America)
29
presentations
1
follower
Professor Stefan James
Uppsala University, UCR-Uppsala Clinical Research Center, Uppsala (Sweden)
32
presentations
0
follower
Professor Roxana Mehran
Icahn School of Medicine at Mount Sinai, New York (United States of America)
29
presentations
1
follower
Professor Stefan James
Uppsala University, UCR-Uppsala Clinical Research Center, Uppsala (Sweden)
32
presentations
0
follower
Professor Roxana Mehran
Icahn School of Medicine at Mount Sinai, New York (United States of America)
29
presentations
1
follower
This platform is supported by